Page last updated: 2024-08-23

paclitaxel and Cancer of Parotid

paclitaxel has been researched along with Cancer of Parotid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, A; Hirano, S; Kinoshita, S; Konishi, E; Mitsuda, J; Mori, D; Ozawa, S; Saburi, S; Takenaka, M; Tsujikawa, T; Yoshimura, K1
Canales Ugarte, S; Cassinello Espinosa, J1

Other Studies

2 other study(ies) available for paclitaxel and Cancer of Parotid

ArticleYear
Radiation-induced angiosarcoma of the parotid gland after postoperative radiotherapy for hypopharyngeal carcinoma.
    Auris, nasus, larynx, 2019, Volume: 46, Issue:6

    Topics: Antineoplastic Agents; Brain Neoplasms; Diagnosis, Differential; Female; Hemangiosarcoma; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Parotid Neoplasms; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck

2019
Cerebral and parotid metachronous metastases from an ovarian carcinoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:11

    Topics: Adenocarcinoma, Mucinous; Anticonvulsants; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Parotid Neoplasms; Supratentorial Neoplasms; Topotecan

2006